Intranasal vaccines for protection against respiratory and systemic bacterial infections. - Wikidata - awgldk - TriplyDB

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

http://www.wikidata.org/entity/Q36837156

about

Vaccines: the Fourth Century Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.A vault nanoparticle vaccine induces protective mucosal immunity.Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.Mucosal vaccination against bacterial respiratory infections.Innate immune control of nucleic acid-based vaccine immunogenicity.Archaeal lipid mucosal vaccine adjuvant and delivery system.Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice.Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.

P2860

Q27490454-2433581F-3C17-460E-B17B-F52EA6E84776 Q33713700-6C0383F5-6FAF-4EB1-8A13-66FD1CB01514 Q35530236-2AD24364-0BC3-4FAF-A2AC-7CD53A9358A3 Q36517179-5C18D9E7-6E8C-406E-882D-58E84999B7DE Q37111626-88535D93-A8C1-4D62-9A30-BB62E20A5824 Q37165790-55E048D2-2F82-43F2-922C-FDEC20E1698D Q37190966-C734FF48-06BD-4AFD-A1D4-37A4597868FF Q37290114-4D9D5CEB-353A-43EA-9A9A-4C0350EB5BFE Q37559651-25F5E43F-99CF-4FFB-BDD4-905DAE84FD22 Q37724863-D607E30C-00FD-4235-B6B1-B20DBD560917 Q39770701-3E9BBC3B-9B3F-4775-BB9D-4FBEFC7BF5DB Q51744963-6986479A-BC51-42ED-B631-8B7A517E70A2

P2860

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

http://www.wikidata.org/entity/Q36837156

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

@en

type

label

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

@en

prefLabel

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

@en

P1433

Q36837156-982A5453-5F67-4FA3-B7B6-51F60B87454C

P1476

Q36837156-070C9B02-1160-4878-88AD-B862FE83E207

P2093

Q36837156-3FB8608A-E2D3-4550-880E-79B5BE50C4B5

Q36837156-F096E9AB-3BF1-4133-98C0-1E0F64DF0492

P2860

Q36837156-0B79E63B-52AD-45E9-9A3D-D6A78ABFD634

Q36837156-0BE7117C-136B-41F1-A51B-917D660F0F89

Q36837156-0D5298CA-CB88-4CCD-876F-0F7C7ADF9F2B

Q36837156-116DD4E5-ABFB-4C57-844D-16E15C721B3E

Q36837156-15CD83D2-CCA6-448A-ADB4-1294A52716B1

Q36837156-162B9ED1-75E9-4A2F-B455-F9F52436CA92

Q36837156-1B48C40A-EBEA-4FF0-ADC7-818736243163

Q36837156-1D8BB098-4BB6-43A8-8CA1-A548DB3D91BA

Q36837156-1DC4DC7B-29B2-41D7-AE27-851AF17BF5CA

Q36837156-1FFAF71B-B91E-4F35-8DCC-C84017301678

P304

Q36837156-70A0AB57-F143-4D20-A83E-E4C6D8CD0551

P31

Q36837156-5D9B8E07-FB7E-46AF-9204-24AAF9F5E251

P356

Q36837156-56E270D9-3416-483B-A865-83049C4B9133

P433

Q36837156-B1ECDD56-B65A-47F3-B839-6E58AF333117

P478

Q36837156-34B7A9F3-6F04-4CE7-BC8F-8A840D046120

P50

Q36837156-D245727F-E38C-4D30-95FA-20F2E554DBFB

P577

Q36837156-0812491A-6F15-467C-BC74-74F79E4E79D0

P698

Q36837156-5A6E50F1-894F-4D17-8C9E-894576862A09

P356

14760584.6.3.419

P1433

Expert Review of Vaccines

P1476

Intranasal vaccines for protection against respiratory and systemic bacterial infections

@en

P2093

Ana Paula Mattos Arêas

http://www.w3.org/2001/XMLSchema#string

Paulo Lee Ho

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Prospects for vaccine prevention of meningococcal infection

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

M cell-targeted DNA vaccination

P304

419-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.6.3.419

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Maria Leonor S. Oliveira

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17542756

http://www.w3.org/2001/XMLSchema#string